CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-07 | Shanler Stuart Chief Scientific Officer | Option exercise · Restricted Stock Units | −5,200 | 3,900 | ||
| 2018-05-07 | Ruffo Frank Chief Financial Officer | Option exercise | +5,200 | 162,065 | ||
| 2018-05-07 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −1,480 | $18.10 | $27K | 160,585 |
| 2018-05-07 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −5,200 | 3,900 | ||
| 2018-05-07 | Powala Christopher Chief Reg & Develop Officer | Option exercise | +5,200 | 138,801 | ||
| 2018-05-07 | Powala Christopher Chief Reg & Develop Officer | Shares withheld for taxes | −1,480 | $18.10 | $27K | 137,321 |
| 2018-05-07 | Powala Christopher Chief Reg & Develop Officer | Option exercise · Restricted Stock Units | −5,200 | 3,900 | ||
| 2018-05-07 | Fair Brett Chief Commercial Officer | Option exercise | +4,050 | 7,191 | ||
| 2018-05-07 | Fair Brett Chief Commercial Officer | Shares withheld for taxes | −1,153 | $18.10 | $21K | 6,038 |
| 2018-05-07 | Fair Brett Chief Commercial Officer | Option exercise · Restricted Stock Units | −4,050 | 3,038 | ||
| 2018-05-07 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +6,933 | 94,610 | ||
| 2018-05-07 | Ali-Jackson Kamil Chief Legal Officer | Shares withheld for taxes | −1,974 | $18.10 | $36K | 92,636 |
| 2018-05-07 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted Stock Units | −6,933 | 5,200 | ||
| 2018-05-07 | Ruffo Frank Chief Financial Officer | Purchase | +1,250 | $18.22 | $23K | 156,865 |
| 2018-04-20 | Reasons Bryan M. Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2018-04-06 | Ruffo Frank Chief Financial Officer | Purchase | +1,250 | $16.59 | $21K | 155,615 |
| 2018-04-06 | Tullman Stephen A. Director | Purchase | +26,700 | $16.54 | $442K | 157,507 |
| 2018-04-06 | Molineaux Christopher P. Director | Sale | +2,300 | $16.52 | $38K | 7,682 |
| 2018-04-05 | Walker Neal President and CEO | Purchase | +10,000 | $16.75 | $168K | 897,184 |
| 2018-03-20 | Molineaux Christopher P. Director | Option exercise | +1,993 | $0.41 | $817 | 9,598 |
Page 46 of 47 · 928 trades